Chinese biotech's $53m IPO joins flurry of HK market activity
Even if Hong Kong's social landscape remains fractured, biotech firms continue to be lured to the HKEX, with Ascentage Pharma the latest to float.
October 23, 2019
Diageo’s $2 billion bid for a 53% stake in India’s United Spirits last Friday marked a rare piece of good news in what has been a dismal year for Indian M&A.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].